GlassScriptPhysician profile
Sean N Jerig
NPI 1437479896
$4,822.25
in general payments reported to CMS, 2019-2025
26 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $225 · 2021: $582 · 2022: $3,212 · 2023: $200 · 2024: $224 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,052.19 | 2022-2023 | Da Vinci Surgical System |
| Daiichi Sankyo INC. | $356.96 | 2019-2025 | Injectafer |
| Minerva Surgical, INC | $192.63 | 2020-2021 | |
| Abbvie INC. | $168.52 | 2019-2023 | |
| Astellas Pharma US INC | $165.50 | 2023-2025 | Veozah |
| Pfizer INC. | $161.17 | 2020-2024 | |
| Hologic Sales and Service, LLC | $118.34 | 2019-2025 | Aptima |
| Exeltis, USA INC. | $104.64 | 2020-2025 | Slynd |
| Mylan Pharmaceuticals INC. | $61.82 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $58.39 | 2022-2025 | |
| Channel Medsystems, INC. | $46.84 | 2022 | |
| Therapeuticsmd, INC. | $45.79 | 2019 | |
| Sumitomo Pharma America, INC. | $36.63 | 2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $33.10 | 2019 | |
| Conmed Corporation | $30.84 | 2023 | Airseal |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.38 | 2020-2021 | |
| Alkermes, INC. | $22.91 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.86 | 2022 | |
| Roche Diagnostics Corporation | $21.00 | 2019 | |
| Sage Therapeutics, LLC | $16.87 | 2025 | Zurzuvae |
| Meditrina | $14.01 | 2024 | |
| Organon LLC | $13.63 | 2022 | |
| Merck Sharp & Dohme LLC | $13.18 | 2022 | |
| Boston Scientific Corporation | $13.13 | 2020 | |
| Aspira Women'S Health INC | $12.53 | 2024 | Ova1 |
| Coopersurgical, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Jerig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.